-
Product Insights
COVID 19 point of care (POC) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021
COVID-19 point of care (POC) tests are used to detect the presence or activity of COVID-19 antigen. This segment includes rapid tests and point of care tests for COVID-19. The COVID-19 POC tests pipeline products report provides comprehensive information about the COVID 19 point of care tests pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The report also provides information on the pipeline products...
-
Product Insights
Reproductive Hormones and Proteins Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021
Reproductive hormones and proteins assist in the control and regulation of physiological processes including metabolism, reproduction, and growth and development. They are secreted either from endocrine glands or from organs with secondary endocrine function (such as the pancreas, liver, kidneys, and gonads) and affect the health and behavior of both males and females. GlobalData's Medical Devices sector report, “Reproductive Hormones and Proteins Tests - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Reproductive Hormones and Proteins Tests...
-
Product Insights
COVID 19 Enzyme Immuno Assay/Enzyme Linked Immunosorbent Assay (EIA/ELISA) – Medical Devices Pipeline Assessment, 2020
COVID 19 EIA/ELISA are the most widely used assays having high sensitivity and specificity. They are used to detect the recombinant protein and peptide antigens in the samples. ELISA’s are specifically designed to screen large number of samples at a time. GlobalData's Medical Devices sector report, “COVID 19 Enzyme Immuno Assay/Enzyme Linked Immunosorbent Assay (EIA/ELISA) -Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the COVID 19 Enzyme Immuno Assay/Enzyme Linked Immunosorbent Assay (EIA/ELISA) pipeline products with comparative analysis of...
-
Product Insights
COVID 19 point of care (POC) Tests – Medical Devices Pipeline Assessment, 2020
COVID 19 Point of Care (POC) Tests are used to detect the presence or activity of COVID-19 antigen. This segment includes rapid tests and point of care tests for COVID-19. GlobalData's Medical Devices sector report, “COVID 19 point of care (POC) Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the COVID 19 point of care (POC) Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which...
-
Sector Analysis
United States In Vitro Diagnostics Market Outlook to 2025 – Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others
GlobalData’s “United States In Vitro Diagnostics Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United States In Vitro Diagnostics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Cardiac Disease, Clinical Chemistry, Hematological Disorders, Hormonal Disorders, Infectious Disease, IVD Analyzers and Reagents, Metabolic Disorder, Oncology and Women's Health. The United States In Vitro Diagnostics Market report provides key information and data on: • Annualized market...